![Tim Knotnerus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tim Knotnerus
Vorstandsvorsitzender bei AgomAb Therapeutics NV
Aktive Positionen von Tim Knotnerus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Vorstandsvorsitzender | 01.01.2019 | - |
Karriereverlauf von Tim Knotnerus
Ehemalige bekannte Positionen von Tim Knotnerus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aescap Venture Management BV
![]() Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Private-Equity-Analyst | 29.06.2011 | 31.05.2012 |
Statistik
International
Niederlande | 2 |
Belgien | 2 |
Operativ
Private Equity Analyst | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Finance | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Aescap Venture Management BV
![]() Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Finance |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
- Börse
- Insiders
- Tim Knotnerus
- Erfahrung